Lv4
730 积分 2024-01-27 加入
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2天前
已关闭
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2天前
已关闭
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2天前
已关闭
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2天前
已关闭
AAV yield, bioactivity and particle heterogeneity are impacted by genome size and non-coding DNA elements
2天前
已完结
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
2天前
已关闭
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
26天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
26天前
已完结
Trends in gene therapy delivery technologies
1个月前
已完结
Accelerated Adeno Associated Virus Upstream Process Development From High‐Throughput Systems to Clinical Scale
1个月前
已完结
皖公网安备34019202002308
